ATHENEX
Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases. Its mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. The company was founded in 2003 in Buffalo, New York, and has since grown to have operations across the U.S., China, Hong Kong, Taiwan, and the U.K.
ATHENEX
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2003-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.athenex.com
Total Employee:
251+
Status:
Active
Contact:
716-427-2950
Email Addresses:
[email protected]
Total Funding:
342.15 M USD
Technology used in webpage:
Google Maps Amazon CrUX Top 50m Microsoft Amazon Ohio Region Shockwave Flash Embed Level 3 Communications Enfold
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Acer Therapeutics
Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
CymaBay Therapeutics
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-04 | Kuur Therapeutics | Kuur Therapeutics acquired by Athenex | 185 M USD |
| 2015-12-14 | Comprehensive Drug Enterprises Ltd | Comprehensive Drug Enterprises Ltd acquired by Athenex | N/A |
| 2014-09-09 | QuaDPharma | QuaDPharma acquired by Athenex | N/A |
Investors List
Kingdon Capital
Kingdon Capital investment in Post-IPO Equity - Athenex
OrbiMed
OrbiMed investment in Post-IPO Equity - Athenex
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Athenex
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Athenex
Mandra Capital
Mandra Capital investment in Private Equity Round - Athenex
Mandra Capital
Mandra Capital investment in Private Equity Round - Athenex
Mandra Capital
Mandra Capital investment in Venture Round - Athenex
Key Employee Changes
Official Site Inspections
http://www.athenex.com Semrush global rank: 7.53 M Semrush visits lastest month: 741
Unable to get host informations!!!
More informations about "Athenex"
Athenex - LinkedIn
Athenex | 5,931 followers on LinkedIn. Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer ...See details»
Athenex - Crunchbase Company Profile & Funding
Athenex is a pharmaceutical company that researches, develops, manufactures, and delivers sterile injectable and compounded products. Buffalo , New York , United States 501-1000See details»
Athenex Company Profile 2024: Valuation, Funding & Investors
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is …See details»
Athenex - Crunchbase Company Profile & Funding
Organization. Athenex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Athenex focuses on the development and …See details»
Athenex, Inc. - AnnualReports.com
Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. The …See details»
Athenex, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Athenex, Inc. with its drug pipeline, therapeutic area, technology platform, 51 clinical trials, 87 news, and 52 literature, Disease Domain:Neoplasms, Immune System Diseases, …See details»
Athenex - Org Chart, Teams, Culture & Jobs - The Org
Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. Industries. Biotechnology, Pharmaceutical. Headquarters. Buffalo, United States. Stage. Post IPO Equity. Employees. 201-500.See details»
Athenex Inc - Company Profile and News - Bloomberg Markets
Company profile page for Athenex Inc including stock price, company news, executives, board members, and contact informationSee details»
Athenex Company Profile - Office Locations, Competitors ... - Craft
Jul 26, 2023 Athenex has 1 employees across 11 locations and $102.82 m in annual revenue in FY 2022. See insights on Athenex including office locations, competitors, revenue, financials, …See details»
Athenex - businessabc
Nov 21, 2024 Athenex was founded in 2002 with a mission of identifying and developing novel, small-molecule therapies for the treatment of cancer. Since then, the company has grown from a two-person start-up to a publicly-traded global pharmaceutical company with more than 400 employees and operations in the United States, China, United Kingdom, and Australia.See details»
Athenex - Funding, Financials, Valuation & Investors - Crunchbase
Athenex is registered under the ticker NASDAQ:ATNX . Their stock opened with $11.00 in its Jun 14, 2017 IPO. Athenex is funded by 4 investors. Kingdon Capital and OrbiMed are the most …See details»
Athenex CEO and Key Executive Team | Craft.co
Athenex's Chief Executive Officer and Board Chairman, Director is Johnson Y.n. Lau. Other executives include Jordan Kanfer, Director; Robert J. Spiegel, Director and 3 others. See the …See details»
Athenex, Inc. Reaches Agreement With Lenders to …
May 14, 2023 To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and Fulfill APD Customer Orders During Process ...See details»
Working At Athenex: Company Overview and Culture - Zippia
Mar 14, 2024 Zippia gives an in-depth look into the details of Athenex, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Athenex. The employee data is based on information from people who have self-reported their past or current employments at Athenex.See details»
Working at Athenex: 16 Reviews - Indeed
Dec 21, 2023 Reviews from Athenex employees about Athenex culture, salaries, benefits, work-life balance, management, job security, and more. Home. Company reviews. Find salaries ... laidback organization. Work was fine sometimes disorganized and inefficient, but in terms of benefits and flexibility it was a great experience. Was this review helpful? Yes No ...See details»
Athenex Announces Appointment of Chief Financial Officer
Feb 22, 2022 Mr. Annoni, Chief Financial Officer, said, “I am honored to join Athenex’s leadership team at such a pivotal time and to lead its finance organization as we refocus the …See details»
Athenex Partners with Leading Contract Manufacturer ... - BioSpace
May 31, 2022 Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of …See details»
Athenex - Contacts, Employees, Board Members, Advisors & Alumni
Athenex is a pharmaceutical company that researches, develops, manufactures, and delivers sterile injectable and compounded products. Search Crunchbase Start Free TrialSee details»
Drugmaker Athenex voluntarily files for U.S. Chapter 11 proceedings
May 14, 2023 The assets to be sold would be across its primary businesses of Athenex Pharmaceutical Division (APD), Orascovery, and Cell Therapy, the company said, adding that …See details»
Athenex Careers and Employment | Indeed.com
Find out what works well at Athenex from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. ... Flexible, easygoing, laidback organization. Work was fine sometimes disorganized and inefficient, but in terms of benefits and flexibility it was a great experience. Inspector in Clarence Center ...See details»